A comprehensive review shows circulating tumour DNA offers powerful prognostic insight across all major mCRPC treatments, but ...

A modeling study finds that adding the Prostate Health Index to prostate cancer screening in Chinese men is cost-effective, ...

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening. Research on more than 12,000 men aged 50 to 74 ...

Martin Sanda, MD, a member of the Winship Cancer Institute, chairman of the Emory Urology Department and internationally recognized prostate cancer scientist, delivered big news about better prostate ...

A new study found the Stockholm3 blood test detected aggressive prostate cancer more accurately than the standard PSA test. Researchers said the test could improve early detection while reducing ...

Cancer Council Australia and the Prostate Cancer Foundation of Australia yesterday released new draft guidelines to help GPs counsel men who ask about prostate cancer tests. They advise GPs to explain ...

A new study shows uneven cervical cancer screening across U.S. regions. Here are current Pap and HPV schedules and at-home testing options. A JAMA Network Open study finds that over 1 million U.S.

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit from 223 Ra radiopharmaceutical therapy and monitor their ...